Three bidentate salicylaldimine nickel complexes containing different long-chain alkyl groups in their ligand backbone were synthesized in good yield. All the bidentate salicylaldimine ligands and their nickel complexes were fully characterized by FT-IR, 1H NMR, UV spectroscopies, and mass spectrometry. Three bidentate nickel complexes were evaluated as catalyst precursors in ethylene oligomerization. Upon activation with methylaluminoxane (MAO), the catalytic activity was 5.75 × 105 g/(mol Ni·h) and the oligomers were mainly butenes (52.10%) and octenes (32.63%) for bidentate nickel complex with 1-tetradecyl as core in the ligand backbone (R14-complex) using toluene as solvent. However, bidentate nickel complex with 1-octadecyl as core in the ligand backbone (R18-complex) produced mainly octenes (59.38%) and C10 + olefins (29.01%) and the catalytic activity was 2.23 × 105 g/(mol Ni·h). After activation with ethylaluminum sesquichloride (EASC) in toluene, three nickel complexes yielded mainly C10 + products which contained Friedel-Craft alkylated-toluene, and their catalytic activities were above 1.5 × 106 g/(mol Ni·h). For the bidentate salicylaldimine nickel catalysts with hyperbranched molecules as ligand backbones, the solvent and the reaction conditions had a large effect on catalytic activity as well as oligomerization distribution except the structure of the catalyst and the co-catalyst.
No takes yet. Share an insight, caveat, or question.
Li et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: